Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Latigo Biotherapeutics, Inc. (LTGO) shares were reported as beneficially owned by 5AM Ventures VI, L.P. and 5AM Opportunities II, L.P., their respective general partners 5AM Partners VI, LLC and 5AM Opportunities II (GP), LLC, and managing members Kush Parmar and Andrew J. Schwab.
As of September 30, 2026, Ventures VI directly held 4,975,543 shares and Opps II directly held 2,350,419 shares. Their respective general partners reported shared voting and dispositive power over those positions. Parmar and Schwab each reported shared voting and dispositive power over 7,325,962 shares, or 11.0%. The reported percentages were based on 66,299,347 shares outstanding as of September 1, 2026.
Key Figures
Direct common shares held by 5AM Ventures VI, L.P.:4,975,543 sharesDirect common shares held by 5AM Opportunities II, L.P.:2,350,419 sharesShared beneficial ownership reported by each of Kush Parmar and Andrew J. Schwab:7,325,962 shares+4 more
7 metrics
Direct common shares held by 5AM Ventures VI, L.P.4,975,543 sharesAs of September 30, 2026; its general partner also reported shared beneficial ownership of this position.
Direct common shares held by 5AM Opportunities II, L.P.2,350,419 sharesAs of September 30, 2026; its general partner also reported shared beneficial ownership of this position.
Shared beneficial ownership reported by each of Kush Parmar and Andrew J. Schwab7,325,962 sharesAs of September 30, 2026; shared power over shares held by both investment vehicles.
Reported ownership percentage for 5AM Ventures VI, L.P. and 5AM Partners VI, LLC7.5%As of September 30, 2026.
Reported ownership percentage for 5AM Opportunities II, L.P. and its general partner3.5%As of September 30, 2026.
Reported ownership percentage for Kush Parmar and Andrew J. Schwab11.0%As of September 30, 2026.
Common shares outstanding66,299,347 sharesAs of September 1, 2026; denominator used for the reported ownership percentages.
Key Terms
beneficially owned, shared voting power, shared dispositive power
3 terms
beneficially ownedregulatory
"securities of the Issuer beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting powerregulatory
"shared voting power over the securities held by Ventures VI"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerregulatory
"shared dispositive power over the securities held by Opps II"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many LTGO shares did Kush Parmar and Andrew J. Schwab report owning?
Kush Parmar and Andrew J. Schwab each reported beneficial ownership of 7,325,962 shares, or 11.0%, as of September 30, 2026. The reported ownership reflects shared power over shares held by 5AM Ventures VI, L.P. and 5AM Opportunities II, L.P.
How many LTGO shares did the 5AM investment vehicles directly hold?
5AM Ventures VI, L.P. directly held 4,975,543 shares, and 5AM Opportunities II, L.P. directly held 2,350,419 shares, as of September 30, 2026.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Latigo Biotherapeutics, Inc.
(Name of Issuer)
Common Stock, $0.0001 par value per share
(Title of Class of Securities)
517954103
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
517954103
1
Names of Reporting Persons
5AM Ventures VI, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,975,543.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,975,543.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,975,543.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.5 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
517954103
1
Names of Reporting Persons
5AM Partners VI, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,975,543.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,975,543.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,975,543.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.5 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
517954103
1
Names of Reporting Persons
5AM Opportunities II, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
2,350,419.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
2,350,419.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,350,419.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.5 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
517954103
1
Names of Reporting Persons
5AM Opportunities II (GP), LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
2,350,419.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
2,350,419.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,350,419.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.5 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
517954103
1
Names of Reporting Persons
Kush Parmar
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
7,325,962.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
7,325,962.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
7,325,962.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
11.0 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
517954103
1
Names of Reporting Persons
Andrew J. Schwab
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
7,325,962.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
7,325,962.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
7,325,962.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
11.0 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Latigo Biotherapeutics, Inc.
(b)
Address of issuer's principal executive offices:
c/o Latigo Biotherapeutics, Inc., 1300 Rancho Conejo Blvd., Suite 305, Thousand Oaks, CA, 91320.
Item 2.
(a)
Name of person filing:
The names of the persons filing this report (collectively, the "Reporting Persons") are:
5AM Ventures VI, L.P. ("Ventures VI")
5AM Partners VI, LLC ("Partners VI")
5AM Opportunities II, L.P. ("Opps II")
5AM Opportunities II (GP), LLC ("Opps II GP")
Kush Parmar ("Dr. Parmar")
Andrew J. Schwab ("Schwab")
The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G.
(b)
Address or principal business office or, if none, residence:
c/o 5AM Ventures
4 Embarcadero Center, Suite 3110
San Francisco, CA 94111
(c)
Citizenship:
Ventures VI Delaware
Partners VI Delaware
Opps II Delaware
Opps II GP Delaware
Dr. Parmar United States
Schwab United States
(d)
Title of class of securities:
Common Stock, $0.0001 par value per share
(e)
CUSIP Number(s):
517954103
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Row 9 of each Reporting Person's cover page to this Schedule 13G sets forth the aggregate number of securities of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and is incorporated by reference.
The Reporting Persons' ownership of the Issuer's securities consists of (i) 4,975,543 shares of common stock held directly by Ventures VI; and (ii) 2,350,419 shares of common stock held directly by Opps II.
Partners VI is the sole general partner of Ventures VI and Dr. Parmar and Schwab are the managing members of Partners VI. Each of Partners VI, Dr. Parmar and Schwab shares voting and dispositive power over the securities held by Ventures VI.
Opps II GP is the sole general partner of Opps II and Dr. Parmar and Schwab are the managing members of Opps II GP. Each of Opps II GP, Dr. Parmar and Schwab shares voting and dispositive power over the securities held by Opps II.
(b)
Percent of class:
Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentage of the shares of common stock of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and is incorporated by reference. The percentage set forth in each row 11 is based upon 66,299,347 shares of common stock outstanding as of September 1, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on September 3, 2026.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Row 5 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and is incorporated by reference.
(ii) Shared power to vote or to direct the vote:
Row 6 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and is incorporated by reference.
(iii) Sole power to dispose or to direct the disposition of:
Row 7 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and is incorporated by reference.
(iv) Shared power to dispose or to direct the disposition of:
Row 8 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and is incorporated by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
5AM Ventures VI, L.P.
Signature:
/s/ Andrew J. Schwab
Name/Title:
By 5AM Partners VI, LLC, its General Partner, By Andrew J. Schwab, Managing Member
Date:
11/16/2026
5AM Partners VI, LLC
Signature:
/s/ Andrew J. Schwab
Name/Title:
By Andrew J. Schwab, Managing Member
Date:
11/16/2026
5AM Opportunities II, L.P.
Signature:
/s/ Andrew J. Schwab
Name/Title:
By 5AM Opportunities II (GP), LLC, its General Partner, By Andrew J. Schwab, Managing Member